Oncology Medicine

Showing 33–48 of 67 results

Mobonib 40 mg (Mobocertinib)
Read more
NiVamo 40 Mg (Nivolumab)
Read more
Olakin 150 mg (Olaparib)
Read more
Olanib 150 mg (Olaparib)
Read more
Osicent 80 mg (Osimertinib)
Read more
Osikin 80 mg (Osimertinib)
Read more
Osimert 80 mg (Osimertinib)
Read more
Osinib 80 mg (Osimertinib)
Read more
Osmigen 80 mg (Osimertinib)
Read more
Palbocent 125 mg (Palbociclib)
Read more
Palboxen 125 mg (Palbociclib)
Read more
Palcigen 125 mg (Palbociclib)
Read more
Paribac 100 mg (Niraparib)
Read more
Peminib 13.5 mg (Pemigatinib)
Read more
Ponaxen 15 mg (Ponatinib)
Read more
Ponaxen 45 mg (Ponatinib)
Read more

←
1
2
3
4
5
→

Onco Medi Cure is dedicated to advancing cancer care through innovative medical solutions, compassionate support, and evidence-based treatments. We strive to bring hope and healing to patients by combining cutting-edge oncology practices with a patient-first approach.

Our Main Office

Dhaka, Bangladesh
01876888861
oncomedicure@gmail.com

Oncology Medicine

Mobonib 40 mg (Mobocertinib)

NiVamo 40 Mg (Nivolumab)

Olakin 150 mg (Olaparib)

Olanib 150 mg (Olaparib)

Osicent 80 mg (Osimertinib)

Osikin 80 mg (Osimertinib)

Osimert 80 mg (Osimertinib)

Osinib 80 mg (Osimertinib)

Osmigen 80 mg (Osimertinib)

Palbocent 125 mg (Palbociclib)

Palboxen 125 mg (Palbociclib)

Palcigen 125 mg (Palbociclib)

Paribac 100 mg (Niraparib)

Peminib 13.5 mg (Pemigatinib)

Ponaxen 15 mg (Ponatinib)

Ponaxen 45 mg (Ponatinib)

Our Main Office

Menu

Category